Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gamma-glutamyltransferase light chain 4 pseudogene (GGTLC4P)
- Target
- GGTLC4P
- Molecular classification
- Other (Pseudogene)
01
Overview
Gamma-glutamyltransferase light chain 4 pseudogene (GGTLC4P) is a member of the gamma-glutamyltransferase gene family that is classified as a pseudogene[7]. Pseudogenes are DNA sequences similar to known genes but are non-functional due to mutations or incomplete sequences, so they do not encode functional proteins. GGTLC4P is named according to its genomic similarity to gamma-glutamyltransferase light chain subunits, but unlike the canonical GGT enzymes (e.g., GGT1), it does not exhibit enzymatic activity, is not involved in glutathione metabolism, and has no recognized physiological or pathological function. There is no evidence supporting a role in human disease, therapeutic intervention, or biomarker use[7]. Its designation as a pseudogene means it simply reflects its sequence similarity to functional GGT genes, lacking relevance to drug targeting or therapeutic mechanism. If you need information on the functional GGT enzymes (like gamma-glutamyltransferase 1 or GGT1), or on other GGT-related pseudogenes, specify accordingly.
- Other names
- GGTgamma-glutamyltransferase pseudogeneGGTLC4Pγ-glutamyl transferase light chain 4 pseudogene
Beyond the preview
Go deeper on Gamma-glutamyltransferase light chain 4 pseudogene (GGTLC4P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gamma-glutamyltransferase light chain 4 pseudogene (GGTLC4P).